mutation status - Globe Thesis

Keyword [mutation status] Result: 21 - 40 \| Page: 2 of 5
21.	The Role Of PET/CT And Fibrinogen In NSCLC Patient With EGFR Mutations
22.	The Correlation Of EGFR Mutation Status With TNM Stage And The Predictor Of Efficacy For EGFR-TKIs (a Multi-center Study) In Non-small Cell Lung Cancer
23.	Correlation Of CT Signs And Pathological Features With EGFR Gene Mutation Status In Peripheral Pulmonary Invasive Adenocarcinoma
24.	Chemotherapy On T790M Mutation Status In Patients With Advanced NSCLC After EGFR-TKI Resistance
25.	Circulating Plasma MicroRNAs As Potential Markers To Identify EGFR Mutation Status And To Monitor Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor Treatment In Patients With Advanced Non-small Cell Lung Cancer
26.	A Clinical Research Of Mutation Status Of CtDNA EGFR In Advanced Non-small-cell Lung Cancer Patients Who Have Been The EGFR Mutation In Tissues
27.	A Preliminary Study Of Lung Adenocarcinoma Linyi Region Of The EGFR Gene Mutation Status
28.	The Correlation Between EGFR Mutation Status And EGFR-TKI Efficacy In Non-small Cell Lung Cancer
29.	The Features Of Brain Metastases From Non-small Cell Lung Cancer According To Epidermal Growth Factor Receptor Mutation Status
30.	Analyzing EGFR Mutation Status Change In Different Sampling Time-points Of Blood Within One Day In Advanced Lung Adenocarcinoma
31.	Prognostic Classification Model For Brain Metastases Of Lung Adenocarcinoma Based On EGFR Mutation Status
32.	Relationship Between EGFR Mutation Status And Histological Subtype And Survival In The New Classification Of Lung Adenocarcinoma
33.	The Detection Of EGFR Mutation Status In Blood In Advanced Non-small Cell Lung Cancer
34.	Analysis Of Clinicopathological Features, Gene Mutation Status And Prognosis Of 52 Lung Cancer Patients Younger Than 35 Years Old: A Retrospective Study
35.	The Relationship Between Parameters From 18F-FDG PET/CT And EGFR、KRAS、 ALK Mutations In NSCLC
36.	The Value Of Spectral CT In The Preoperative Differential Diagnosis Of SPN Benign And Malignant And Assessing EGFR Mutation Status
37.	Exploratory Study On EGFR Gene Mutation Status And EGFR-TKI Efficacy In Patients With LncRNAs With Advanced NSCLC
38.	Computed Tomography,Clinical Features And Tumor Markers Associated With Epidermal Growth Factor Receptor Mutation Status In Lung Adenocarcinoma
39.	The Value Of ¹⁸F-FDG PET-CT Metabolic Parameters In Predicting The Epidermal Growth Factor Receptor Mutation Status In Lung Adenocarcinoma
40.	Analysis Of The EGFR Mutation Status And Curative Effect In 82 Patients Of Advanced Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to